AEterna Zentaris Inc. Message Board
-
Anthera Initiates CHABLIS-SC1 Phase 3 Clinical Study in Lupus with Blisibimod
-
Just a question.
-
Rosetta Genomics announces credentialing agreement with Prime Health Services for miRview mets2 Co announces that the Company has executed a credentialing agreement with Prime Health Services, Inc, a managed care company that offers a full spectrum of services, including a Preferred Provider Organization (PPO +0.61%, news), for the inclusion of Rosetta Genomics' miRview mets2 test in Prime Health's covered products and services. The agreement with Prime Health is the first credentialing agreement executed between Rosetta Genomics and a U.S. PPO, and increases the number of covered lives for which its miRview mets2 test could be adjudicated as "in-network" to more than 6.5 million.
Sentiment: Strong Buy
-
If history repeats, we could see $18.00 by July, just like 10 month ago.
-
Did you read Seeking Alpha?
-
I beleive there waiting to tell us around 4pm today.
- Reply to
Patrick Rodgers, CPA, PA NEW, Public Accounting Company
by carynorth2000 •Apr 29, 2013 7:51 AMWelcome to the world of pink sheet stocks, go big or go home?
-
Possible reason for the upside move in tagglikeme.
-
During Mr. Dodd's six-year tenure as President, CEO and Director of Serologicals Corporation, the market value of that company increased from $85 million in June 2000 to an all-cash sale to Millipore Corporation in July 2006 for $1.5 billion. That successful transformation followed his five-year term as President and CEO of Solvay Pharmaceuticals, Inc. and as Chairman of its subsidiary Unimed Pharmaceuticals, Inc. Prior to that, Mr. Dodd held various senior management positions at Wyeth-Ayerst Laboratories, the Mead Johnson Laboratories Division at Bristol-Myers Squibb, and Abbott Laboratories.
-
Nice action today, somethings going on, especially when posters are trying
to knock down the share price. -
Anything over $1.80 according to the chart is a considered a break out stock...
-
I agree with 2 out of 4 of you, this is an amazing pump and it will happen, just don't know when.
-
I will wait, ether I go down with the ship, or in the next 20 years I break even on the next pump.
I W I L L W A I T ! -
Just bought ONCS! Great new oncology product to save many lives.
-
Major breakout around .235 Big blocks this morning.
-
-
The Business Summary both sound the same.
-
Scientists Unlock Hidden Potential Of Cutting-Edge Cancer Drugs
Main Category: Cancer / Oncology
Article Date: 21 Mar 2013 - 2:00 PDT
Scientists Unlock Hidden Potential Of Cutting-Edge Cancer Drugs
A class of cutting-edge cancer drugs could keep patients alive for much longer than they do now following a major new discovery about exactly how they attack tumors.